ENOUGH

The company produces ABUNDA® mycoprotein, a food ingredient derived from fermenting fungi with sugars from renewable feedstocks like grains. This process is significantly more resource-efficient than traditional animal protein production, using substantially less water and feed while generating fewer CO2 emissions. The resulting mycoprotein is a whole food ingredient rich in protein and fiber, containing all nine essential amino acids. It has a neutral taste and a fibrous, meaty texture, making it a versatile component for developing alternatives to meat, fish, and dairy products.

ENOUGH operates on a business-to-business (B2B) model, supplying its ABUNDA® ingredient to food manufacturers, retailers, and food service companies. This strategy aims to accelerate the adoption of sustainable protein by enabling other companies to expand their plant-based product lines. The company has a production facility in Sas van Gent, Netherlands, strategically co-located with a Cargill facility that supplies the necessary glucose feedstock. ENOUGH has an ambitious goal to produce one million tonnes of mycoprotein cumulatively by 2032.

The company has successfully raised significant capital to fund its expansion, with total funding surpassing €110 million from multiple rounds. Key investors include CPT Capital, Nutreco, Cargill, World Fund, and Scottish Enterprise. These investments are being used to scale up production capacity to meet the increasing demand from the alternative protein market.